Concomitant chemoradiotherapy versus induction chemotherapy followed by chemoradiotherapy as definitive,first line treatment of squamous cell carcinoma of the head and neck

Strahlentherapie und Onkologie

Volumn 190, Issue 3, 2014, Pages 256-262

  Balermpas, P ^a   Bauer, C ^a   Fraunholz, I ^a   Ottinger, A ^a   Wagenblast, J ^a   Stover T ^a   Seitz, O ^a   Fokas, E ^a   Rodel C ^a   Weiss, C ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Head and neck neoplasms; Induction chemotherapy; Multimodality treatment; Organ preservation; Survival analysis

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; FLUOROURACIL; MITOMYCIN;

ADULT; ADVANCED CANCER; ANEMIA; ARTICLE; BRAIN HEMORRHAGE; CANCER CHEMOTHERAPY; CHEMORADIOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG FATALITY; FEMALE; FOLLOW UP; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEART DISEASE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; OVERALL SURVIVAL; PATIENT COMPLIANCE; RADIATION DERMATITIS; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CHEMORADIOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; HUMANS; INDUCTION CHEMOTHERAPY; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; OTORHINOLARYNGOLOGIC NEOPLASMS; RETROSPECTIVE STUDIES; TAXOIDS;

EID: 84896356493     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-013-0509-9     Document Type: Article

References (22)

1. Alongi F, Bignardi M, Garassino I et al (2012) Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patients. Strahlenther Onkol 188:49-55
2. Duma MN, Kampfer S, Schuster T et al (2012) Adaptive radiotherapy for soft tissue changes during helical tomotherapy for head and neck cancer. Strahlenther Onkol 188:243-247
3. Adelstein DJ, Li Y, Adams GL et al (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21:92-98
4. Brizel DM, Albers ME, Fisher SR et al (1998) Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338:1798-1804 (Pubitemid 28277960)
5. Budach V, Stuschke M, Budach W et al (2005) Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-scalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J Clin Oncol 23:1125-1135 (Pubitemid 46202268)
6. Pignon JP, le Maitre A, Maillard E et al (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:4-14
7. Paccagnella A, Ghi MG, Loreggian L et al (2010) Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study. Ann Oncol 21:1515-1522
8. Haddad R, O'Neill A, Rabinowits G et al (2013) Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial. Lancet Oncol 14:257-264
9. Hitt R, Grau JJ, Lopez-Pousa A et al (2009) Final results of a randomized phase III trial comparing induction chemotherapy with cisplatin/5-FU or docetaxel/cisplatin/5-FU follow by chemoradiotherapy (CRT) versus CRT alone as first-line treatment of unresectable locally advanced head and neck cancer (LAHNC). J Clin Oncol 27(15 Suppl): 6009
10. Cohen EEW, Karrison T, Kocherginsky M et al (2012) DeCIDE: a phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN). ASCO Meeting Abstracts 30:5500
11. Johansen LV, Grau C, Overgaard J (2000) Hypopharyngeal squamous cell carcinoma - treatment results in 138 consecutively admitted patients. Acta Oncol 39:529-536
12. Rades D, Seibold ND, Gebhard MP et al (2013) Impact of the HPV-positivity definition on the prognostic value of HPV status in patients with locally advanced squamous cell carcinoma of the head and neck. Strahlenther Onkol 189:856-860
13. Sadat F, Wienke A, Dunst J et al (2012) Survival of patients with head and neck cancer. Impact of physical status and comorbidities. Strahlenther Onkol 188:62-70
14. Jeremic B, Milicic B (2009) Pretreatment prognostic factors of survival in patients with locally advanced nonmetastatic squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy. Am J Clin Oncol 32:163-168
15. Vermorken JB, Remenar E, Herpen C van et al (2007) Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357:1695-1704 (Pubitemid 350005151)
16. Posner MR, Hershock DM, Blajman CR et al (2007) Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357:1705-1715 (Pubitemid 350005152)
17. Wendt TG, Grabenbauer GG, Rodel CM et al (1998) Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 16:1318-1324 (Pubitemid 28175746)
18. Ghi MG, Paccagnella A, Ferrari D et al (2013) A phase II-III study comparing concomitant chemoradiotherapy (CRT) versus cetuximab/RT (CET/RT) with or without induction docetaxel/cisplatin/5-fluorouracil (TPF) in locally advanced head and neck squamous cell carcinoma (LASCCHN): efficacy results (NCT01086826). ASCO Meeting Abstracts 31:6003
19. Bromme JO, Schmucking M, Arnold A et al (2013) Taxane-containing induction chemotherapy followed by definitive chemoradiotherapy: outcome in patients with locally advanced head and neck cancer. Strahlenther Onkol 189:618-624
20. Caudell JJ, Hamilton RD, Otto KJ et al (2012) Induction docetaxel, cisplatin, and 5-fluorouracil precludes definitive chemoradiotherapy in a substantial proportion of patients with head and neck cancer in a low socioeconomic status population. Am J Clin Oncol
21. Forastiere AA, Adelstein DJ, Manola J (2013) Induction chemotherapy meta-analysis in head and neck cancer: right answer, wrong question. J Clin Oncol 31:2844-2846
22. Blanchard P, Bourhis J, Lacas B et al (2013) Taxane-cisplatin- fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group. J Clin Oncol 31:2854-2860